BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, December 15, 2025
Home » Newsletters » BioWorld MedTech

BioWorld MedTech

June 15, 2012

View Archived Issues

72nd Annual ADA Scientific Sessions: Italian firm resurrects lasers for measurement of glucose

PHILADELPHIA The first attempt at using a technology for medical applications does not always work, but Gulya (Como, Italy) says there is life left in lasers as a means for checking glucose levels. Emanuel Bosi, MD, director of department of medicine at Ospedale San Raffaele (Milan, Italy), made the trip to the U.S. to give attendees at this year's edition of the scientific sessions by the American Diabetes Association (ADA; Alexandria, Virginia) a look at Gulya's pilot study, which Bosi said was encouraging enough to push the company to invest more in the idea. Read More

Mazor pushes onward to gain approval for brain procedures

Read More

Report from Europe: Endosense completes study enrollment for TactiCath

Read More

NewCo on the Block: Auxogyn aims to improve IVF outcomes with Eeva

Read More

Deals roundup: FTC clears J&J-Synthes deal, closing expected Thursday

Read More

People in the News

Read More

Patent watch: Aeris's lung-volume therapy will treat emphysema patients

Read More

Grants roundup: Holy Cross receives $4M gift to help expand facility

Read More

Agreements/contracts: RF Surgical to provide Assure to HealthTrust

Read More

Court report: PST sues ClearCount over patent infringement claims

Read More

HIT roundup: ICF wins IDIQ contract by HHS, NIH, and NITAAC

Read More

Product Briefs

Read More

Med-Tech Notes: Zynex acquires internet domain

Read More

MDD's Ortho Extra

Read More

FDA advisory committee: Sapien aces vote for high-risk patients at advisory meeting

GAITHERSBURG, Maryland The Sapien transcatheter aortic valve replacement (TAVR) made by Edwards Lifesciences (Irvine, California) aced its way through a second advisory committee vote earlier this week, the second such outcome in the past year for the device. The circulatory systems advisory committee gave the device's use in inoperable patients a nod last July by a vote of 9-0 that the benefits outweighed the risks, and the vote for patients at high risk for surgery won a convincing 11-0 vote as well, although one panelist abstained from voting. Read More

Svelte Medical launches FAASTER study in Europe

Read More

Report from Europe: Boston Sci treats first patient with Latitude NXT

Read More

Avinger completes enrollment in CONNECT II trial for PAD

Read More

Agreements/contracts: Teleflex to provide CVCs to HealthTrust Group

Read More

Deals roundup: Vascular Solutions acquires splint business from Accumed

Read More

Financings roundup: Invuity raises $25M in 'D' round to expand product line

Read More

Court report: CryoLife settles patent litigation with CardioFocus

Read More

Patent watch: Sanovas gets coverage for Vas Zeppelin technology

Read More

Med-Tech Notes: Aptiv Solutions maintains ISO certification

Read More

People in the News

Read More

Product Briefs

Read More

Cordis issues 'urgent' recall on Fire Star Rx catheters

Read More

MDD's Diagnostic Extra

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 12, 2025.
  • Novo Nordisk semaglutide pill

    CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

    BioWorld
    A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
  • Acute myeloid leukemia illustration

    Apollo’s APL-4098 shows potent antileukemic effects

    BioWorld Science
    Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
  • Illustration of brain with electrical activity background

    ABS-1230 controls seizures in KCNT1-driven severe epilepsy

    BioWorld Science
    Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing